Pablo de Olavide University

Pablo de Olavide University
Short name
UPO
Country, city
Spain, Seville
Publications
6 365
Citations
168 840
h-index
145
Top-3 journals
Sustainability
Sustainability (89 publications)
Scientific Reports
Scientific Reports (84 publications)
Top-3 organizations
University of Seville
University of Seville (983 publications)
Instituto de la Grasa
Instituto de la Grasa (240 publications)
University of Granada
University of Granada (229 publications)
Top-3 foreign organizations
University of Porto
University of Porto (76 publications)
University of Cambridge
University of Cambridge (67 publications)
University of Lisbon
University of Lisbon (52 publications)

Most cited in 5 years

Found 
from chars
Publications found: 2252
Role and Responsibilities of Various Stakeholders in Pharmacovigilance (PV)
Phougat P., Beniwal M., Kapoor G., Aggarwal N., Kumari A., Sharma R., Chopra H., Sharma R., Kamal M.A.
Q3
Bentham Science Publishers Ltd.
Current Drug Safety 2025 citations by CoLab: 2  |  Abstract
Abstract:: In this review paper, we have analyzed the potential and issues associated with Pharmacovigilance (PV). The analysis is divided into four sections: background, stakeholders, data sources, and medicinal chemistry. Each section discusses the current state, the future trends, and the best practices of Pharmacovigilance (PV). The main purpose, methods, results, and implications of our analysis are summarized. Background:: Pharmacovigilance (PV) is the science and practice of monitoring, evaluating, understanding, and preventing adverse drug reactions. Pharmacovigilance (PV) was established by the World Health Organization in response to the thalidomide tragedy of 1961. The main purpose of Pharmacovigilance (PV) is to ensure the safety and efficacy of drugs in clinical practice. Stakeholders:: Pharmacovigilance (PV) involves various stakeholders, such as patients, pharmacists, pharmaceutical companies, healthcare professionals, and regulatory authorities. Each stakeholder has a different role and responsibility in reporting, processing, analyzing, and communicating information about adverse drug reactions. Patient engagement is a key factor for enhancing Pharmacovigilance (PV) practices. Data Sources:: Pharmacovigilance (PV) relies on data from various sources, such as clinical trials, spontaneous reports, electronic medical records, biomedical literature, and patient-reported data in online health forums. These data sources can provide valuable insights into the real-world use and safety of drugs, as well as the preferences and needs of patients. However, these data sources also pose challenges in terms of quality, validity, reliability, and accessibility. Medicinal Chemistry:: Medicinal chemistry is the branch of chemistry that deals with the design, synthesis, and evaluation of new drugs and their biological effects. Medicinal chemistry can enhance Pharmacovigilance (PV) practices by finding new therapeutic indications for existing drugs or compounds that have already been tested for safety and efficacy. Medicinal chemistry also requires careful design and evaluation of covalent inhibitors, bi-substrate inhibitors, stabilizers of protein non-effective conformations, and hydrophobic pocket modifiers to ensure their safety and efficacy. Implications:: Pharmacovigilance (PV) is a dynamic and evolving discipline that requires collaboration, regulation, education, and innovation to improve patient safety and care. This review aims to provide a comprehensive overview of the potential and issues associated with Pharmacovigilance (PV) practices.
A Comprehensive Review on Nanoparticles as Drug Delivery System and Their Role for Management of Hypertension
Prerna, Bhatt D.C., Mir K.B., Kumar V., Rathor S.
Q2
Bentham Science Publishers Ltd.
Current Pharmaceutical Biotechnology 2025 citations by CoLab: 1  |  Abstract
<p>The current global epidemic of hypertension is not a disease in and of itself but rather a significant risk factor for serious cardiovascular conditions such as peripheral artery disease, heart failure, myocardial infarction, and stroke. Although many medications that work through various mechanisms of action are available on the market in conventional formulations to treat hypertension, these medications face significant difficulties with their bioavailability, dosing, and associated side effects, which significantly reduces the effectiveness of their therapeutic interventions. Numerous studies have shown that nanocarriers and nanoformulations can minimize the toxicity associated with high doses of the drug while greatly increasing the drug's bioavailability and reducing the frequency of dosing. </p> <p> This review sheds light on the difficulties posed by traditional antihypertensive formulations and highlights the necessity of oral nanoparticulate systems to solve these issues. Because hypertension has a circadian blood pressure pattern, chronotherapeutics can be very important in treating the condition. On the other hand, nanoparticulate systems can be very important in managing hypertension.</p>
Feasting on the Future: Unveiling Edible Insects as a Sustainable Food with Enriched Health Benefits
Kumar A., Goyal N., Pramanik J., Joia S., Singh S., Prajapati B.G.
Q3
Bentham Science Publishers Ltd.
Current Nutrition and Food Science 2025 citations by CoLab: 1  |  Abstract
Abstract: Animal- and plant-based foods are considered staple foods worldwide. As the population increases, new alternative foods with higher nutritional value and sustainable nature are needed. Moreover, the current food system drastically impacts the environment and may result in unsustainability. The livestock sector significantly contributes to greenhouse gas emissions and is a major user of land and water resources. Additionally, excessive animal farming adversely affects the environment, accelerating climate change. To solve these problems, alternative and eco-friendly food resources that offer proper nutritional and health benefits are needed. Although edible insects have been used through several civilizations, they have emerged as an exciting and promising approach. Edible insects can transform various organic products into high-quality proteins with essential amino acids, including agricultural and food waste products. Edible insects are nutritionally rich and contain healthy fatty acids such as lauric acid, oleic acid, and omega 3 and 6. In addition, edible insect production requires much less resources, such as water and land, and emits significantly less greenhouse gases, thus contributing to sustainable food production. This review provides a comprehensive understanding of the nutritional profile, sustainability aspects, and health benefits of edible insects.
Comparative Evaluation of Cefixime Microspheres Utilizing a Natural Polymer and a Synthetic Polymer
Arora D., Taneja Y., Sharma A., Sharma P., Jatin, Guarve K., Rani N., Verma I.
Q3
Bentham Science Publishers Ltd.
Current Drug Therapy 2025 citations by CoLab: 0  |  Abstract
Background:: Microspheres are naturally biodegradable, free-flowing powders with a particle size of less than 200 micrometres that are comprised of proteins or synthetic polymers. Using microspheres is a reliable strategy to ensure that the drug is accurately delivered to the target area and that the right concentration is kept there without having any unfavourable side effects. Objective:: The objective of the present study was to create a sustained-release cefixime trihydrate microsphere delivery system employing natural and synthetic polymers as a carrier and increase therapeutic effectiveness. Methods:: Due to the simplicity of processing, the solvent injection method was used to create microspheres. Microspheres were created with this technology using the sustained-release polymer, sodium alginate, and active material (drug). The compatibility of components with the drug was evaluated using XRD and FT-IR. In an in-vitro release research, the dissolving medium was phosphate buffer at pH 6.8. For the kinetic analysis of the drug release mechanism, graphs for zero-order, first-order, Higuchi's, Korsmeyer-Peppas, and Hixson-Crowell models were also created. Results:: The best formulation was chosen from the batches, and in-vitro cefixime trihydrate release studies for various microspheres containing cefixime trihydrate in phosphate buffer (pH 7.4) for 8 hours were performed. The dissolution profiles of formulations F4 and F8 showed that the formulation, including xanthan gum, F8, released 55.01% more medication in 8 hours than the formulation using HPMC, F4. X-ray diffraction, swelling index of drug-laden microspheres, and Scanning Electron Microscopy were used to evaluate formulation F8. The graphs for zero-order, first-order, Higuchi's, Korsmeyer-Peppas, and Hixson- Crowell models were plotted, and the optimised batch was discovered to match Higuchi's drug release kinetics with an R2 value of 0.990. Conclusion:: Cefixime trihydrate microspheres can be utilized as a new drug delivery technology to minimize dose frequency and, as a result, to promote patient compliance.
Anticancer Potential of Pineapple and its Bioactive Compound Bromelain
Kumar D., Suchitra, Mundlia J., Yadav S.K., Yadav D., Aggarwal N., Chopra H., Kumar V., Kamal M.A.
Q2
Bentham Science Publishers Ltd.
Current Pharmaceutical Design 2025 citations by CoLab: 0
Open Access
Open access
 |  Abstract
Abstract: Various ailments have been treated with pineapple [Ananas comosus (L.) Merr.] throughout medicinal history. Pineapple and its bioactive compound bromelain possess health-promoting benefits. Detailed information on the chemotherapeutic activities of pineapple and its bioactive compound bromelain is provided in this review, which analyses the current literature regarding their therapeutic potential in cancer. Research on disease models in cell cultures is the focus of much of the existing research. Several studies have demonstrated the benefits of pineapple extract and bromelain for in vitro and in vivo cancer models. Preliminary animal model results show promise, but they must be translated into the clinical setting. Research on these compounds represents a promising future direction and may be well-tolerated.
Anti-inflammatory and Anti-arthritic Properties of Mucuna gigantea Plant Extracts: Establishing by Molecular Docking Study
kumar S., Srivastava P., Mujwar S., Gauttam V., Gupta S.
Q3
Bentham Science Publishers Ltd.
Current Computer-Aided Drug Design 2025 citations by CoLab: 0  |  Abstract
Background: Mucuna giganteais a traditional plant reported in the management of nervous disorders, male infertility, etc., and also exhibits aphrodisiac, anti-oxidant, and anti-diabetic properties. Very few studies are conducted on Mucuna gigantea. It has not been pharmacologically evaluated for rheumatoid arthritis (RA). In RA, the body's natural defence mechanism gets confused and begins to target the healthy tissues in the body, which leads to joint pain, swelling, bone erosion, and joint stiffness. It is a condition that is classified as an auto-immune disorder. Methods: In-silico docking depicted that beta-sitosterol is present in Mucuna gigantea out of ligand library prepared based on a literature survey using computational analysis. Inflammation was induced by carrageen and chronic inflammation was induced by Freund’s complete adjuvant in the plantar surface of the rats. The petroleum ether, ethanolic and aqueous extracts in three divided doses (75, 150, and 300 mg/kg) were administered orally. Diclofenac sodium (10 mg/kg), prednisolone (5 mg/kg), and methotrexate (0.5 mg/kg) were used as standard. The statistical significance between means was analyzed using one-way ANOVA, followed by Dunnett’s multiple range test. The values are expressed as mean ± SD for each group (n=6), and aP<0.0001, bP<0.001, and cP<0.05 were compared with a negative control group. Results: Ethanolic and petroleum ether extracts showed a statistically significant aP<0.0001 effect at 3hr with 300mg/kg effect in analgesic activity, whereas aqueous extracts showed statistically significant aP<0.0001 effect at 1.5hr with 150 and 300mg/kg. In the carrageen-induced model, all three extracts at 300 mg/kg showed a statistically significant aP<0.0001 effect from 2- 4hr. In Freund’s adjuvant model, all three extracts at all doses showed a statistically significant aP<0.0001 effect. Also, Mucuna gigantea remarkably ameliorated altered WBCs, rheumatoid factor, and positively modified radiographic and histopathological changes. Conclusion: Taken together, these results support the traditional use of Mucuna gigantea as a potent anti-inflammatory and anti-arthritic agent that may be proposed for rheumatoid arthritis treatment.
A Concise Review on Magnetic Nanoparticles: Their Properties, Types, Synthetic Methods, and Current Trending Applications
M. M., R. B., Kumar S.K., R. S.K.
Q3
Bentham Science Publishers Ltd.
Current Nanoscience 2025 citations by CoLab: 1  |  Abstract
Abstract: In recent years, there has been significant research on developing magnetic nanoparticles (MNPs) with multifunctional characteristics. This review focuses on the properties and various types of MNPs, methods of their synthesis, and biomedical, clinical, and other applications. These syntheses of MNPs were achieved by various methods, like precipitation, thermal, pyrolysis, vapor deposition, and sonochemical. MNPs are nano-sized materials with diameters ranging from 1 to 100 nm. The MNPs have been used for various applications in biomedical, cancer theranostic, imaging, drug delivery, biosensing, environment, and agriculture. MNPs have been extensively researched for molecular diagnosis, treatment, and therapeutic outcome monitoring in a range of illnesses. They are perfect for biological applications, including cancer therapy, thrombolysis, and molecular imaging, because of their nanoscale size, surface area, and absence of side effects. In particular, MNPs can be used to conjugate chemotherapeutic medicines (or) target ligands/proteins, making them beneficial for drug delivery. However, up until that time, some ongoing issues and developments in MNPs include toxicity and biocompatibility, targeting accuracy, regulation and safety, clinical translation, hyperthermia therapy, immunomodulatory effects, multifunctionality, and nanoparticle aggregation.
Serum Gamma Glutamyl Transferase: Understanding its Contribution as a Potential Predictor of the Occurrence of Type 2 Diabetes
Anupam S., Goel S., Bhatti K., Mehta D.K., Das R.
Q2
Bentham Science Publishers Ltd.
Current Diabetes Reviews 2025 citations by CoLab: 4  |  Abstract
Introduction: The liver and kidneys are the primary locations of the glutathione metabolism enzyme gamma-glutamyl transferase (GGT). The two main factors contributing to an increase are hepatic illnesses and excessive alcohol use. This study set out to test a theory on the predictive importance of the association between GGT and Type 2 diabetes mellitus. (T2DM). Methods: In order to do this, we combed through PubMed, Google Scholar, Medline, and Science Direct for a wide range of information from previous studies. Attributes were established at the outset and compared to GGT concentration. Result: GGT, present in most cells, absorbs glutathione for intracellular antioxidant defences. This study links GGT to hepatic enzymes including HDL, LDL, and triglyceride. LDL, triglycerides, AST, and ALT increased with GGT concentration, but LDL decreased. Because of obesity, GGT production rises with BMI. We found that greater GGT levels were associated with more T2DM after analysing data from multiple sources. Conclusion: This literature review concludes that GGT is related to other factors such as BMI, HDL, AST, and triglycerides in the development of diabetes mellitus. Serum GGT was found to be a potential predictor of metabolic syndrome and T2DM
Evaluation of Moringa Oleifera Leaf Extract for its In vitro Antibacterial Properties, Mechanism of Action, and In vivo Corneal Ulcer Healing Effects in Rabbits’ Eyes
Bibi A., dhanawat M., Aman S., Chauhan S., Chalotra R., Mujwar S., Kaur N., Maivagna C., Gupta S.
Q2
Bentham Science Publishers Ltd.
Current Drug Delivery 2025 citations by CoLab: 0  |  Abstract
Background: M. oleifera is the most adapted tree species in different medicinal eco-systems and has resilience against climate changes. This multiple-use tree provides healthy foods, snacks, honey, and fuel. Besides this, it has immense promising applications by offering antimicrobial and antibacterial activities for targeted uses. This validates the court of Hippocrates that let food be the medicine and medicine be the food for which moringa qualifies. Objective: The objective of this study is to assess the antioxidant properties of M. oleifera, in vitro antibacterial activity of hydro-ethanolic extract, and further investigate in vivo healing potential of M. oleifera for corneal ulcers and in silico analysis. Methods: To evaluate the antioxidant and in vitro antibacterial potency of the hydro-ethanolic extract of M. oleifera on clinically isolated multidrug-resistant strains of Staphylococcus aureus using agar well diffusion assay. Furthermore, in vivo, healing response of M. oleifera extract was analysed on corneal ulcers induced in rabbit eyes infected with methicillin-resistant Staphylococcus aureus. Results: The M. oleifera extract exhibited exponential antioxidant activity. In-vitro antibacterial activity was evaluated by agar well diffusion assay showing zone of inhibition ranging from 11.05 ± 0.36 to 20 ± 0.40 mm at concentrations of 20, 40, 80, and 160 mg/ml, whereas, in our finding, no zone of inhibition was observed below 20 mg/ml concentration, which indicated that there is threshold limit below which the antibacterial activity of M. oleifera extract is not observed. Furthermore, continuous application of 3% and 5% M. oleifera extract (eye drop) four times a day for 14 consecutive days showed a significant healing response of the eyes of rabbits with corneal ulcers. Conclusion: These results suggest that M. oleifera extract could be a viable alternative or in combination could be used in existing antibacterial therapies for corneal ulcers. Additionally, there is a possibility of commercial formulation of M. oleifera extract in the form of deliverable pharmaceutical products; therefore, it should be explored further.
The Gut Microbiota-Brain Axis: A New Frontier in Alzheimer's Disease Pathology
dhanawat M., Malik G., Wilson K., Gupta S., Gupta N., Sardana S.
Q2
Bentham Science Publishers Ltd.
CNS and Neurological Disorders - Drug Targets 2025 citations by CoLab: 1  |  Abstract
Abstract: Dr. Aloysius Alzheimer, a German neuropathologist and psychiatrist, recognized the primary instance of Alzheimer's disease (AD) for a millennium, and this ailment, along with its related dementias, remains a severe overall community issue related to health. Nearly fifty million individuals worldwide suffer from dementia, with Alzheimer's illness contributing to between 60 and 70% of the instances, estimated through the World Health Organization. In addition, 82 million individuals are anticipated to be affected by the global dementia epidemic by 2030 and 152 million by 2050. Furthermore, age, environmental circumstances, and inherited variables all increase the likelihood of acquiring neurodegenerative illnesses. Most recent pharmacological treatments are found in original hypotheses of disease, which include cholinergic (drugs that show affective cholinergic system availability) as well as amyloid-accumulation (a single drug is an antagonist receptor of Nmethyl D-aspartate). In 2020, the FDA provided approval on anti-amyloid drugs. According to mounting scientific data, this gut microbiota affects healthy physiological homeostasis and has a role in the etiology of conditions that range between obesity and neurodegenerative disorders like Alzheimer's. The microbiota-gut-brain axis might facilitate interconnection among gut microbes as well as the central nervous system (CNS). Interaction among the microbiota-gut system as well as the brain occurs through the “two-way” microbiota-gut-brain axis. Along this axis, the stomach as well as the brain develop physiologically and take on their final forms. This contact is constant and is mediated by numerous microbiota-derived products. The gut microbiota, for instance, can act as non-genetic markers to set a threshold for maintaining homeostasis or getting ill. The scientific community has conducted research and found that bowel dysbiosis and gastrointestinal tract dysregulation frequently occur in Alzheimer's disease (AD) patients. In this review, the effects of the microbiota- gut-brain axis on AD pathogenesis will be discussed.
Bioactive Milk Peptides as a Nutraceutical Opportunity and Challenges
Kapoor D.U., Gaur M., Kumar A., Ansari M.N., Prajapati B.
Q2
Bentham Science Publishers Ltd.
Current Protein and Peptide Science 2025 citations by CoLab: 1  |  Abstract
Abstract: The biotechnology field has witnessed rapid advancements, leading to the development of numerous proteins and peptides (PPs) for disease management. The production and isolation of bioactive milk peptides (BAPs) involve enzymatic hydrolysis and fermentation, followed by purification through various techniques such as ultrafiltration and chromatography. The nutraceutical potential of bioactive milk peptides has gained significant attention in nutritional research, as these peptides may regulate blood sugar levels, mitigate oxidative stress, improve cardiovascular health, gut health, bone health, and immune responses, and exhibit anticancer properties. However, to enhance BAP bioavailability, the encapsulation method can be used to offer protection against protease degradation and controlled release. This article provides insights into the composition, types, production, isolation, bioavailability, and health benefits of BAPs.
A recent update on Ayurvedic anti-asthmatic formulations: Highlighting the role of major anti-asthmatic plants
Chaudhary J., Bhatia M., Jain A., Sonam, Dhingra A., Chopra B.
Q3
Bentham Science Publishers Ltd.
Current Traditional Medicine 2024 citations by CoLab: 0  |  Abstract
Abstract: Asthma is a chronic heterogeneous airway obstruction disorder defined by a complex cascade of pathophysiological conditions that lead to recurring bronchial hyper-responsiveness and underlying inflammation, lowering the patient’s quality of life. Despite the availability of various synthetic medications for the management of asthma, it has become one of the leading causes of death worldwide. Furthermore, the present allopathic treatment possesses severe long-term negative effects, which make people more attracted to the safer and easily available indigenous traditional and Ayurvedic system of medicine. Ayurveda is regarded as the “Mother of all healing” and “Science of Life,” which treats all the ailments, including asthma, by restoring a balance between three main components of the body- Vata, Pitta, and Dosha. Various clinically effective and less toxic anti-asthmatic Ayurvedic herbal preparations are available for the management of asthma and related complications which act by causing mast cell deactivation, inhibition of Th1, Th2, Th7 response, T-cell suppression, etc., therefore, efforts have been made to compile all the relevant literature related to the ayurvedic anti-asthmatic formulations and scrutinize the efficacy of selected plants present in the majority in those formulations in asthma along with the structure and mode of action of phytoconstituent responsible for designing novel molecules with better efficacy. Research on these selected plants can also have economic significance as various constituents isolated from these plants for their anti-asthmatic effect can further be explored to discover their potential in medicinal, diagnostic and cosmetic field.
Convection-enhanced Diffusion: A Novel Tactics to Crack the BBB
Dhanawat M., Garima, Wilson K., Gupta S., Chalotra R., Gupta N.
Q2
Bentham Science Publishers Ltd.
Current Drug Delivery 2024 citations by CoLab: 0  |  Abstract
Abstract: Although the brain is very accessible to nutrition and oxygen, it can be difficult to deliver medications to malignant brain tumours. To get around some of these issues and enable the use of therapeutic pharmacological substances that wouldn't typically cross the blood-brain barrier (BBB), convection-enhanced delivery (CED) has been developed. It is a cutting-edge strategy that gets beyond the blood-brain barrier and enables targeted drug administration to treat different neurological conditions such as brain tumours, Parkinson's disease, and epilepsy. Utilizing pressure gradients to spread the medicine across the target area is the main idea behind this diffusion mechanism. Through one to several catheters positioned stereotactically directly within the tumour mass, around the tumour, or in the cavity created by the resection, drugs are given. This method can be used in a variety of drug classes, including traditional chemotherapeutics and cutting-edge investigational targeted medications by using positive-pressure techniques. The drug delivery volume must be optimized for an effective infusion while minimizing backflow, which causes side effects and lowers therapeutic efficacy. Therefore, this technique provides a promising approach for treating disorders of the central nervous system (CNS).
The Fascinating Effects of Flavonoids on Lung Cancer: A Review
Singh D., dhanawat M., Verma I., Gupta S.
Q3
Bentham Science Publishers Ltd.
Current Nutrition and Food Science 2024 citations by CoLab: 0  |  Abstract
Abstract: Lung cancer has emerged as one of the most often reported illnesses and leading causes of mortality worldwide. Inefficient, lack of safety, low therapeutic index, unpleasant effects, and excessive cost have led to a loss of trust in synthetic medications, limiting their use. Natural compounds have good anticancer potential without unwanted toxic effects. Among them, flavonoids are the most important compounds. Flavonoids are polyphenolic chemical compounds abundant in fruits and vegetables and are essential in preventing lung cancer. Their potent anticancer effects are said to be based on a wide range of biological actions, such as antioxidants, anti-mutagenesis, anti-inflammation, and differentiation induction, preventing cancer cell proliferation through regulating signal transduction pathways, triggering cell cycle arrest, and activating apoptosis or autophagy; anti-invasion; anti-metastasis, altering cancer cell drug resistance and increasing sensitization to chemotherapy. This review illustrates the most recent advancements in flavonoids in lung cancer and their associated molecular mechanisms using information from scientific research studies like in vitro and in vivo clinical trials. It takes these data into theory and practice.
An Updated Review on Nanoemulsion: Factory for Food and Drug Delivery
Kumar V., Garg V., Saini N., Aggarwal N., Kumar H., Kumar D., Chopra H., Kamal M.A., Dureja H.
Q2
Bentham Science Publishers Ltd.
Current Pharmaceutical Biotechnology 2024 citations by CoLab: 0  |  Abstract
Background: A nanoemulsion is a colloidal system of small droplets dispersed in another liquid. It has attracted considerable attention due to its unique properties and various applications. Throughout this review, we provide an overview of nanoemulsions and how they can be applied to various applications such as drug delivery, food applications, and pesticide formulations. Objective: This updated review aims to comprehensively overview nanoemulsions and their applications as a versatile platform for drug delivery, food applications, and pesticide formulations. Methods: Research relevant scientific literature across various databases, including PubMed, Scopus, and Web of Science. Suitable keywords for this purpose include "nanoemulsion," "drug delivery," and "food applications." Ensure the search criteria include recent publications to ensure current knowledge is included. Results: Several benefits have been demonstrated in the delivery of drugs using nanoemulsions, including improved solubility, increased bioavailability, and controlled delivery. Nanoemulsions have improved some bioactive compounds in food applications, including vitamins and antioxidants. At the same time, pesticide formulations based on nanoemulsions have also improved solubility, shelf life, and effectiveness. Conclusion: The versatility of nanoemulsions makes them ideal for drug delivery, food, and pesticide formulation applications. These products are highly soluble, bioavailable, and targeted, providing significant advantages. More research and development are required to implement nanoemulsion-based products on a commercial scale.

Since 1999

Total publications
6365
Total citations
168840
Citations per publication
26.53
Average publications per year
244.81
Average authors per publication
6.74
h-index
145
Metrics description

Top-30

Fields of science

50
100
150
200
250
300
350
400
450
Molecular Biology, 406, 6.38%
General Medicine, 399, 6.27%
Ecology, Evolution, Behavior and Systematics, 346, 5.44%
Genetics, 297, 4.67%
Cell Biology, 285, 4.48%
Plant Science, 285, 4.48%
Economics and Econometrics, 281, 4.41%
Multidisciplinary, 261, 4.1%
Ecology, 261, 4.1%
Biochemistry, 257, 4.04%
Physical and Theoretical Chemistry, 257, 4.04%
Physical Therapy, Sports Therapy and Rehabilitation, 222, 3.49%
Computer Science Applications, 214, 3.36%
General Biochemistry, Genetics and Molecular Biology, 205, 3.22%
Orthopedics and Sports Medicine, 205, 3.22%
Geography, Planning and Development, 203, 3.19%
General Chemistry, 197, 3.1%
Management, Monitoring, Policy and Law, 195, 3.06%
General Physics and Astronomy, 193, 3.03%
Renewable Energy, Sustainability and the Environment, 191, 3%
Food Science, 176, 2.77%
Strategy and Management, 156, 2.45%
Public Health, Environmental and Occupational Health, 155, 2.44%
General Materials Science, 150, 2.36%
Sociology and Political Science, 144, 2.26%
Developmental Biology, 140, 2.2%
Physiology, 138, 2.17%
Microbiology, 127, 2%
Business and International Management, 118, 1.85%
General Neuroscience, 115, 1.81%
50
100
150
200
250
300
350
400
450

Journals

10
20
30
40
50
60
70
80
90
10
20
30
40
50
60
70
80
90

Publishers

200
400
600
800
1000
1200
1400
1600
200
400
600
800
1000
1200
1400
1600

With other organizations

100
200
300
400
500
600
700
800
900
1000
100
200
300
400
500
600
700
800
900
1000

With foreign organizations

10
20
30
40
50
60
70
80
10
20
30
40
50
60
70
80

With other countries

100
200
300
400
500
600
700
800
USA, 788, 12.38%
United Kingdom, 551, 8.66%
Germany, 351, 5.51%
Italy, 305, 4.79%
France, 290, 4.56%
Mexico, 228, 3.58%
Portugal, 226, 3.55%
Chile, 222, 3.49%
Netherlands, 219, 3.44%
China, 204, 3.21%
Switzerland, 199, 3.13%
Brazil, 186, 2.92%
Australia, 173, 2.72%
Belgium, 150, 2.36%
Canada, 136, 2.14%
Argentina, 96, 1.51%
Sweden, 88, 1.38%
Denmark, 86, 1.35%
Japan, 84, 1.32%
Poland, 76, 1.19%
Czech Republic, 61, 0.96%
Colombia, 59, 0.93%
Austria, 56, 0.88%
Finland, 55, 0.86%
South Africa, 53, 0.83%
Israel, 49, 0.77%
Peru, 48, 0.75%
Iran, 44, 0.69%
Ireland, 44, 0.69%
100
200
300
400
500
600
700
800
  • We do not take into account publications without a DOI.
  • Statistics recalculated daily.
  • Publications published earlier than 1999 are ignored in the statistics.
  • The horizontal charts show the 30 top positions.
  • Journals quartiles values are relevant at the moment.